Area of research
Genetics · Epidemiology
Research interest
Research focused on Crohn's disease and Clinical trial, with related work in Calprotectin, Scopus, Crohn disease. Notable publications include 'Challenges and Opportunities in IBD Clinical Trial Design', 'Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment', and 'Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies'.
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies
Challenges and Opportunities in IBD Clinical Trial Design